| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP1019077A4 Novel exendin agonist compounds |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0937063B1 Aryloxypropanolamine derivatives, method of preparation and applications thereof |
| 04/10/2002 | EP0732329B1 Chroman derivative |
| 04/10/2002 | EP0661990B1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 04/10/2002 | CN1344321A Screening method |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344271A Remedies |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344245A Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 04/10/2002 | CN1344162A Medical compsns. |
| 04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/10/2002 | CN1344159A Combinations for treatment of diseases involving angiogenesis |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343502A Ulcer medicine for treating subcutaneous ulcer |
| 04/10/2002 | CN1082374C Application of remulus mori alcohol and/or water soaked cream for preparing medicine of reducing blood sugar |
| 04/10/2002 | CN1082370C Pharmaceutical compsn. contg. 4-oxo-butynic acid |
| 04/10/2002 | CN1082369C Formulations contg. carotenoids and procarotenoids combined with polyphenols |
| 04/09/2002 | US6369273 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 04/09/2002 | US6369232 Antidiabetic agents |
| 04/09/2002 | US6369222 mGluR antagonists and a method for their synthesis |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369201 For increasing muscle synthesis and treating disease in vertebrate subjects, for reducing myostatin activity |
| 04/09/2002 | US6369113 Antidepressants, parkinson's disease |
| 04/09/2002 | US6369103 Hmg coa reductase inhibitor such as pravastatin to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane |
| 04/09/2002 | US6369088 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369075 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/09/2002 | US6369065 CD40 signal blocking agent |
| 04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 04/09/2002 | US6368624 Homogenizing, cooling leaves, freeze drying |
| 04/09/2002 | US6368621 Preparation in particular for use as a medication and/or food supplement |
| 04/09/2002 | US6368597 Methods of treating diabetes |
| 04/09/2002 | US6368580 Gastrointestinal disorders; oral administering bacillus |
| 04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
| 04/09/2002 | CA2071224C Quinoline derivatives, their production and use |
| 04/09/2002 | CA2048842C Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents |
| 04/04/2002 | WO2002027318A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | WO2002027008A1 Promoter sequences |
| 04/04/2002 | WO2002026997A2 Dsp-16 dual-specificity phosphatase |
| 04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/04/2002 | WO2002026833A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/04/2002 | WO2002026829A1 Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis |
| 04/04/2002 | WO2002026826A2 Proteins and nucleic acids encoding same |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026774A2 Melanocortin receptor ligands |
| 04/04/2002 | WO2002026752A1 α-SUBSTITUTED β-AMINOETHYL PHOSPHONATES |
| 04/04/2002 | WO2002026743A1 Novel pyridazine compounds for the treatment of diabetes |
| 04/04/2002 | WO2002026737A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| 04/04/2002 | WO2002026736A1 A thiazolidinedione derivative and its use as antidiabetic |
| 04/04/2002 | WO2002026735A1 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026717A2 Hydroxy acid integrin antagonists |
| 04/04/2002 | WO2002026707A1 Novel compounds |
| 04/04/2002 | WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
| 04/04/2002 | WO2002026245A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions |
| 04/04/2002 | WO2002026243A1 Composition for diminishing neutral fat in blood |
| 04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
| 04/04/2002 | WO2002026216A1 Pharmaceutical oxan preparation |
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2002000042A3 Compositions and methods for body weight management |
| 04/04/2002 | WO2001097837A8 Solubilised protein vaccines |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | WO2001088532A3 Improved assay techniques using nematode worms |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085784A3 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072839A3 Human g-protein coupled receptors |
| 04/04/2002 | WO2001072829A3 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 04/04/2002 | WO2001066098A3 Therapeutic uses of ppar mediators |
| 04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2001047898A3 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 04/04/2002 | WO2001047522A3 Association of deoxyfructosazine and an antidiabetic of the biguanide family |
| 04/04/2002 | WO2000064454A9 Pharmaceutical composition comprising an inositol and a metal ion for improving insulin sensitivity and glucose metabolism |
| 04/04/2002 | WO2000063193A9 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them |
| 04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
| 04/04/2002 | US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent |
| 04/04/2002 | US20020040063 Liquid formulation of metformin |
| 04/04/2002 | US20020040054 Comprehensive pharmacologic therapy for treatment of obesity |
| 04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 04/04/2002 | US20020040023 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists |
| 04/04/2002 | US20020040016 Derivatives of azetidine and pyrrolidine |
| 04/04/2002 | US20020040014 Novel aryl fructose-1,6-Bisphosphatase inhibitors |